Variant report

Variant	nsv963972
Chromosome Location	chr2:211922680-211928471
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:211918949..211922416-chr2:211922605..211926396,3	MCF-7	breast:

Extended variants
information (count: 95 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:95 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs537152353	chr2:211925219-211925220	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs369383926	chr2:211925266-211925267	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs571938960	chr2:211925313-211925314	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs78687612	chr2:211925329-211925330	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs542137146	chr2:211925345-211925346	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs188196436	chr2:211925433-211925434	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs572795121	chr2:211925475-211925476	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs192617813	chr2:211925526-211925527	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs551472415	chr2:211925539-211925540	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs551116124	chr2:211925543-211925544	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs564476743	chr2:211925553-211925554	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs113746235	chr2:211925561-211925562	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs147328718	chr2:211925576-211925577	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs371795254	chr2:211925580-211925581	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs543934777	chr2:211925581-211925582	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs76594625	chr2:211925587-211925588	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs529111615	chr2:211925647-211925648	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs548784512	chr2:211925657-211925658	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs565603109	chr2:211925702-211925703	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs112408805	chr2:211925706-211925707	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs550914578	chr2:211925723-211925724	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs571266786	chr2:211925749-211925750	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs536732615	chr2:211925796-211925797	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs371946934	chr2:211925797-211925798	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs189014902	chr2:211925806-211925807	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs567272576	chr2:211925828-211925829	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs146206087	chr2:211925835-211925836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs374881602	chr2:211925852-211925853	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs565415259	chr2:211925924-211925925	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs556341697	chr2:211925967-211925968	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs369299592	chr2:211926004-211926005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs139163370	chr2:211926008-211926009	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs59226190	chr2:211926024-211926025	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs149463508	chr2:211926028-211926029	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs558176513	chr2:211926059-211926060	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs569713193	chr2:211926072-211926073	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs184708213	chr2:211926092-211926093	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs189058149	chr2:211926101-211926102	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs141709361	chr2:211926123-211926124	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs375475941	chr2:211926127-211926128	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs181493971	chr2:211926172-211926173	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs558447524	chr2:211926243-211926244	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs113369456	chr2:211926282-211926283	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs542371457	chr2:211926303-211926304	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs199770330	chr2:211926306-211926307	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs559125862	chr2:211926318-211926319	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs528367128	chr2:211926337-211926338	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs201534896	chr2:211926385-211926386	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs551297461	chr2:211926394-211926395	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs376437022	chr2:211926418-211926419	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Testicular germ cell tumor	18059402	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Non-muscle invasive bladder neoplasm	19445696	CNVD
Non-small cell lung cancer	21829676	CNVD
Autism	20808228	CNVD
Renal cell carcinoma	18765545	CNVD
Ovarian cancer	19193619	CNVD
Non-small cell lung cancer	18676828	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	18923514	CNVD
Schizophrenia	22241247	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Urothelial cell carcinoma	18451213	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Bipolar disorder	19114987	CNVD
Schizophrenia	21346763	CNVD

Chromatin state (count:11 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:211925200-211925400	Enhancers	Fetal Intestine Large	intestine
2	chr2:211925400-211926400	Weak transcription	Fetal Intestine Large	intestine
3	chr2:211925600-211926600	Enhancers	Fetal Intestine Small	intestine
4	chr2:211926200-211926600	Enhancers	Rectal Mucosa Donor 31	rectum
5	chr2:211926200-211927200	Enhancers	HepG2	liver
6	chr2:211926400-211927200	Enhancers	Liver	Liver
7	chr2:211926400-211927200	Enhancers	Fetal Intestine Large	intestine
8	chr2:211926400-211927400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
9	chr2:211926600-211926800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr2:211926800-211927600	Enhancers	Adipose Nuclei	Adipose
11	chr2:211928400-211930600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links